The introduction of a gene-editing bill to parliament on 25th May marked a monumental step in the post-Brexit era. Since 2018, it has been nearly impossible to grow gene-edited food in the EU at a commercial scale. However, now free to make its own regulations, the UK is seizing the chance to unlock its significant R&D infrastructure and reap the security and nutritional benefits of gene-editing.

Agrifood encompasses the entire food supply chain, from agriculture production to food consumption. Every human is a stakeholder in the agrifood system and supply chain, as they are all elements of the natural environment.

A new fund to boost life science innovation was revealed by Sir Jon Symonds at the Global Genomics Conference, as the current Chairman of GSK hinted at a raft of upcoming major policy proposals for life sciences and genomics.

Despite its size, Iceland has emerged as a pioneer of carbon capture and storage (CCS) technologies. As part of the Pathway to COP programme, the World Economic Series (WES) hosted by PPP and Diplomat Magazine explored how Iceland’s experience can inform other countries seeking to develop carbon management strategies – and how they can further collaborate in their efforts.

With the advanced therapy and medicinal product (ATMP) landscape looking positive, Public Policy Projects are exploring the challenges to gene and cell therapy adoption and how the UK can build upon its successes in the post-pandemic environment.